Works matching IS 00070920 AND DT 2023 AND VI 128 AND IP 8

Results: 21
    1
    2

    Genomic ALK alterations in primary and relapsed neuroblastoma.

    Published in:
    British Journal of Cancer, 2023, v. 128, n. 8, p. 1559, doi. 10.1038/s41416-023-02208-y
    By:
    • Rosswog, Carolina;
    • Fassunke, Jana;
    • Ernst, Angela;
    • Schömig-Markiefka, Birgid;
    • Merkelbach-Bruse, Sabine;
    • Bartenhagen, Christoph;
    • Cartolano, Maria;
    • Ackermann, Sandra;
    • Theissen, Jessica;
    • Blattner-Johnson, Mirjam;
    • Jones, Barbara;
    • Schramm, Kathrin;
    • Altmüller, Janine;
    • Nürnberg, Peter;
    • Ortmann, Monika;
    • Berthold, Frank;
    • Peifer, Martin;
    • Büttner, Reinhard;
    • Westermann, Frank;
    • Schulte, Johannes H.
    Publication type:
    Article
    3

    Utility of molecular subtypes and genetic alterations for evaluating clinical outcomes in 1029 patients with endometrial cancer.

    Published in:
    British Journal of Cancer, 2023, v. 128, n. 8, p. 1582, doi. 10.1038/s41416-023-02203-3
    By:
    • Asami, Yuka;
    • Kobayashi Kato, Mayumi;
    • Hiranuma, Kengo;
    • Matsuda, Maiko;
    • Shimada, Yoko;
    • Ishikawa, Mitsuya;
    • Koyama, Takafumi;
    • Komatsu, Masaaki;
    • Hamamoto, Ryuji;
    • Nagashima, Minoru;
    • Terao, Yasuhisa;
    • Itakura, Atsuo;
    • Kohno, Takashi;
    • Sekizawa, Akihiko;
    • Matsumoto, Koji;
    • Kato, Tomoyasu;
    • Shiraishi, Kouya;
    • Yoshida, Hiroshi
    Publication type:
    Article
    4
    5
    6
    7

    Clinical significance of circulating-tumour DNA analysis by metastatic sites in pancreatic cancer.

    Published in:
    British Journal of Cancer, 2023, v. 128, n. 8, p. 1603, doi. 10.1038/s41416-023-02189-y
    By:
    • Umemoto, Kumiko;
    • Sunakawa, Yu;
    • Ueno, Makoto;
    • Furukawa, Masayuki;
    • Mizuno, Nobumasa;
    • Sudo, Kentaro;
    • Kawamoto, Yasuyuki;
    • Kajiwara, Takeshi;
    • Ohtsubo, Koushiro;
    • Okano, Naohiro;
    • Matsuhashi, Nobuhisa;
    • Itoh, Shinji;
    • Matsumoto, Toshihiko;
    • Shimizu, Satoshi;
    • Otsuru, Toru;
    • Hasegawa, Hiroko;
    • Okuyama, Hiroyuki;
    • Ohama, Hideko;
    • Moriwaki, Toshikazu;
    • Ohta, Takashi
    Publication type:
    Article
    8
    9
    10
    11
    12
    13

    Dietary intake of total, heme and non-heme iron and the risk of colorectal cancer in a European prospective cohort study.

    Published in:
    British Journal of Cancer, 2023, v. 128, n. 8, p. 1529, doi. 10.1038/s41416-023-02164-7
    By:
    • Aglago, Elom K.;
    • Cross, Amanda J.;
    • Riboli, Elio;
    • Fedirko, Veronika;
    • Hughes, David J.;
    • Fournier, Agnes;
    • Jakszyn, Paula;
    • Freisling, Heinz;
    • Gunter, Marc J.;
    • Dahm, Christina C.;
    • Overvad, Kim;
    • Tjønneland, Anne;
    • Kyrø, Cecilie;
    • Boutron-Ruault, Marie-Christine;
    • Rothwell, Joseph A.;
    • Severi, Gianluca;
    • Katzke, Verena;
    • Srour, Bernard;
    • Schulze, Matthias B.;
    • Wittenbecher, Clemens
    Publication type:
    Article
    14
    15
    16

    Ferroptosis in colorectal cancer: a future target?

    Published in:
    British Journal of Cancer, 2023, v. 128, n. 8, p. 1439, doi. 10.1038/s41416-023-02149-6
    By:
    • Yan, Hong;
    • Talty, Ronan;
    • Aladelokun, Oladimeji;
    • Bosenberg, Marcus;
    • Johnson, Caroline H.
    Publication type:
    Article
    17

    Manassantin A inhibits tumour growth under hypoxia through the activation of chaperone-mediated autophagy by modulating Hsp90 activity.

    Published in:
    British Journal of Cancer, 2023, v. 128, n. 8, p. 1491, doi. 10.1038/s41416-023-02148-7
    By:
    • Byun, Jun-Kyu;
    • Lee, Sun Hee;
    • Moon, Eui Jung;
    • Park, Myo-Hyeon;
    • Jang, Hyeonha;
    • Weitzel, Douglas H.;
    • Kim, Hyun-Hwi;
    • Basnet, Nikita;
    • Kwon, Do-Yeon;
    • Lee, Chen-Ting;
    • Stephenson, Tesia N.;
    • Jeong, Ji-Hak;
    • Patel, Bhargav A.;
    • Park, Sung Jean;
    • Chi, Jen-Tsan;
    • Dewhirst, Mark W.;
    • Hong, Jiyong;
    • Lee, You Mie
    Publication type:
    Article
    18
    19
    20

    INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line

    Published in:
    British Journal of Cancer, 2023, v. 128, n. 8, p. 1503, doi. 10.1038/s41416-022-02108-7
    By:
    • Colombo, N.;
    • Gadducci, A.;
    • Sehouli, J.;
    • Rulli, E.;
    • Mäenpää, J.;
    • Sessa, C.;
    • Montes, A.;
    • Ottevanger, N. B.;
    • Berger, R.;
    • Vergote, I.;
    • D'Incalci, M.;
    • Churruca Galaz, C.;
    • Chekerov, R.;
    • Nyvang, G. B.;
    • Riniker, S.;
    • Herbertson, R.;
    • Fossati, R.;
    • Barretina-Ginesta, M. P.;
    • Deryal, M.;
    • Mirza, M. R.
    Publication type:
    Article
    21